These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 20678190)

  • 1. Antenatal HIV-1 RNA load and timing of mother to child transmission; a nested case-control study in a resource poor setting.
    Duri K; Gumbo FZ; Kristiansen KI; Kurewa NE; Mapingure MP; Rusakaniko S; Chirenje MZ; Muller F; Stray-Pedersen B
    Virol J; 2010 Aug; 7():176. PubMed ID: 20678190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of antenatal plasma cytomegalovirus DNA levels on pregnancy outcome and HIV-1 vertical transmission among mothers in the University of Zimbabwe birth cohort study (UZBCS).
    Duri K; Chimhuya S; Gomo E; Munjoma PT; Chandiwana P; Yindom LM; Mhandire K; Ziruma A; Mtapuri-Zinyowera S; Mazengera LR; Misselwitz B; Gumbo FZ; Jordi S; Rowland-Jones S;
    Virol J; 2021 Jan; 18(1):30. PubMed ID: 33514390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Siegfried N; van der Merwe L; Brocklehurst P; Sint TT
    Cochrane Database Syst Rev; 2011 Jul; (7):CD003510. PubMed ID: 21735394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of maternal viral load on the risk of perinatal transmission of HIV-1. New York City Perinatal HIV Transmission Collaborative Study Group.
    Thea DM; Steketee RW; Pliner V; Bornschlegel K; Brown T; Orloff S; Matheson PB; Abrams EJ; Bamji M; Lambert G; Schoenbaum EA; Thomas PA; Heagarty M; Kalish ML
    AIDS; 1997 Mar; 11(4):437-44. PubMed ID: 9084790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human Immunodeficiency Virus (HIV) types Western blot (WB) band profiles as potential surrogate markers of HIV disease progression and predictors of vertical transmission in a cohort of infected but antiretroviral therapy naïve pregnant women in Harare, Zimbabwe.
    Duri K; Müller F; Gumbo FZ; Kurewa NE; Rusakaniko S; Chirenje MZ; Mapingure MP; Stray-Pedersen B
    BMC Infect Dis; 2011 Jan; 11():7. PubMed ID: 21211021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Volmink J; Siegfried NL; van der Merwe L; Brocklehurst P
    Cochrane Database Syst Rev; 2007 Jan; (1):CD003510. PubMed ID: 17253490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maternal Humoral Immune Responses Do Not Predict Postnatal HIV-1 Transmission Risk in Antiretroviral-Treated Mothers from the IMPAACT PROMISE Study.
    Hompe ED; Jacobson DL; Eudailey JA; Butler K; Edwards W; Pollara J; Brummel SS; Fouda GG; Chinula L; Kamanga M; Kinikar A; Moodley D; Owor M; Fowler MG; Permar SR
    mSphere; 2019 Oct; 4(5):. PubMed ID: 31645430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial.
    ; de Vincenzi I
    Lancet Infect Dis; 2011 Mar; 11(3):171-80. PubMed ID: 21237718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
    Sturt AS; Dokubo EK; Sint TT
    Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Independent effects of nevirapine prophylaxis and HIV-1 RNA suppression in breast milk on early perinatal HIV-1 transmission.
    Chung MH; Kiarie JN; Richardson BA; Lehman DA; Overbaugh J; Njiri F; John-Stewart GC
    J Acquir Immune Defic Syndr; 2007 Dec; 46(4):472-8. PubMed ID: 18077838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uptake and performance of prevention of mother-to-child transmission and early infant diagnosis in pregnant HIV-infected women and their exposed infants at seven health centres in Addis Ababa, Ethiopia.
    Girma M; Wendaferash R; Shibru H; Berhane Y; Hoelscher M; Kroidl A
    Trop Med Int Health; 2017 Jun; 22(6):765-775. PubMed ID: 28407452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term virological outcomes in women who started option B+ care during pregnancy for prevention of mother-to-child transmission of HIV in Dar es Salaam, Tanzania: a cohort study.
    Lyatuu GW; Mwashemele SZ; Urrio R; Naburi H; Kashmir N; Machumi L; Kibao A; Sellah Z; Ulenga N; Orsini N; Biberfeld G; Kilewo C; Ekström AM
    Lancet HIV; 2021 May; 8(5):e256-e265. PubMed ID: 33581776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling of In-Utero and Intra-Partum Transmissions to Evaluate the Efficacy of Interventions for the Prevention of Perinatal HIV.
    Sripan P; Le Coeur S; Amzal B; Ingsrisawang L; Traisathit P; Ngo-Giang-Huong N; McIntosh K; Cressey TR; Sangsawang S; Rawangban B; Kanjanavikai P; Tréluyer JM; Jourdain G; Lallemant M; Urien S
    PLoS One; 2015; 10(5):e0126647. PubMed ID: 25992639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A post-partum single-dose TDF/FTC tail does not prevent the selection of NNRTI resistance in women receiving pre-partum ZDV and intrapartum single-dose nevirapine to prevent mother-to- child HIV-1 transmission.
    Samuel R; Paredes R; Parboosing R; Moodley P; Singh L; Naidoo A; Gordon M
    J Med Virol; 2015 Oct; 87(10):1662-7. PubMed ID: 25940687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pregnancy Profile and Infant Outcomes Among HIV Infected Women Who Delivered in Cipto Mangunkusumo Hospital.
    Indarti J; Yunihastuti E; Kurniati N; Aprilia B; Pamungkas DT; Chiprion AT; Ginting MA; Rizal S; Dewi C; Handayani L
    Acta Med Indones; 2020 Jan; 52(1):55-62. PubMed ID: 32291372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extended antenatal use of triple antiretroviral therapy for prevention of mother-to-child transmission of HIV-1 correlates with favorable pregnancy outcomes.
    Marazzi MC; Palombi L; Nielsen-Saines K; Haswell J; Zimba I; Magid NA; Buonomo E; Scarcella P; Ceffa S; Paturzo G; Narciso P; Liotta G
    AIDS; 2011 Aug; 25(13):1611-8. PubMed ID: 21673553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies against pneumococcal capsular polysaccharide in Malawian HIV-positive mothers and their HIV-exposed uninfected children.
    Baroncelli S; Galluzzo CM; Mancinelli S; Andreotti M; Jere H; Amici R; Marazzi MC; Vella S; Palombi L; Giuliano M
    Infect Dis (Lond); 2016 Apr; 48(4):317-321. PubMed ID: 26609569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maternal plasma viral load, zidovudine and mother-to-child transmission of HIV-1 in Africa: DITRAME ANRS 049a trial.
    Leroy V; Montcho C; Manigart O; Van de Perre P; Dabis F; Msellati P; Meda N; You B; Simonon A; Rouzioux C;
    AIDS; 2001 Mar; 15(4):517-22. PubMed ID: 11242149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach.
    Tonwe-Gold B; Ekouevi DK; Viho I; Amani-Bosse C; Toure S; Coffie PA; Rouet F; Becquet R; Leroy V; El-Sadr WM; Abrams EJ; Dabis F
    PLoS Med; 2007 Aug; 4(8):e257. PubMed ID: 17713983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integration of postpartum healthcare services for HIV-infected women and their infants in South Africa: A randomised controlled trial.
    Myer L; Phillips TK; Zerbe A; Brittain K; Lesosky M; Hsiao NY; Remien RH; Mellins CA; McIntyre JA; Abrams EJ
    PLoS Med; 2018 Mar; 15(3):e1002547. PubMed ID: 29601570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.